What is the translation of " SAFETY AND TOLERABILITY " in Chinese?

• 安全性和耐受性

Examples of using Safety and tolerability in English and their translations into Chinese

Primary outcome: Safety and tolerability.
主要终点：安全性和耐受性.

Safety and tolerability served as primary endpoints.
安全性和耐受性被定义为主要终点。

It also assessed the treatment's safety and tolerability.
我们还评估了治疗的可接受性和安全性。

Safety and tolerability were also continuously monitored.
研究对安全性和耐受性也进行了持续监测。

The study will also assess safety and tolerability of the drug.
还评估了药物安全性和耐受性。

Safety and tolerability of VGX-3100 will also be measured.
该研究还将评估VGX-3100的安全性和耐受性。

The primary endpoints for this clinical trial are safety and tolerability.
该临床试验的主要终点是安全性和耐受性。

Moreover, safety and tolerability of the drugs will be assessed.
还评估了药物安全性和耐受性。

The primary objectives of this clinical trial are safety and tolerability.
该临床试验的主要终点是安全性和耐受性。

The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators.
该研究中PT010的安全性和耐受性与双联对照药物的已知概况一致。

Purpose of the study is also to evaluate the safety and tolerability of copanlisib.
本研究的目的也包括评价copanlisib的安全性和耐受性。

Across both trials, the safety and tolerability of Calquence were consistent with its established profile.
项研究中，Calquence的安全性和耐受性与已确定的轮廓一致。

In addition to the primary endpoint of PFS, secondary endpoints included OS, safety and tolerability.
除了主要终点PFS，次要终点包括OS、安全性和耐受性。

Better safety and tolerability, lower rate of hepatotoxicity, no need to monitor liver function on a monthly basis.
安全性和耐受性更好，肝脏毒性作用更小，无需每月监测肝功能；.

The primary endpoint was OS, and key secondary endpoints included PFS, safety and tolerability.
除了主要终点PFS，次要终点包括OS、安全性和耐受性。

The primary objective of the study was to assess the safety and tolerability of elenbecestat after 18 months of treatment.
本研究的主要目标是评估经过18个月的治疗后，Elenbecestat表现出的安全性和耐受性。

Key secondary endpoints include overall survival, overall response rate, PFS by investigator, and safety and tolerability.
关键次要终点包括总生存期、总体缓解率、研究者评估的PFS、安全性和耐受性。

Regarding safety and tolerability, no substantial differences in the number of adverse events observed between treatment groups were obvious.
关于安全性的特征，在接受观察的不同治疗组之间没有发现显著性差异。

Now, having bored you with my lengthy sermon on the scientific literature supporting statin safety and tolerability, let's look at real world experience.
现在，让你厌倦了我关于支持他汀类药物安全性和耐受性的科学文献的长篇布道，让我们看看现实世界的经验。

The trial's primary outcome will examine safety and tolerability with secondary endpoints measuring changes in cognition, function, and behavior in these patients.
试验的主要结果将检查安全性和耐受性，次要终点测量这些患者的认知、功能和行为的变化。

Throughout the clinical development program, ALKS 5461 demonstrated a consistent profile of antidepressant activity, safety and tolerability in the adjunctive treatment of MDD.
在整个临床开发项目中，ALKS5461在MDD的辅助治疗中表现出一致的抗抑郁疗效、安全性和耐受性。

Secondary objectives included evaluating the safety and tolerability of bempedoic acid versus placebo and its effects on other risk markers, including hsCRP.
次要终点是评估bempedoicacid的安全性和耐受性，以及对其它风险标志物（包括hsCRP）的影响。

Other endpoints included progression-free survival, overall response rate determined by investigator and the safety and tolerability of this combination in this patient population.
其他终点包括由研究人员确定的无恶化生存和总缓解率以及联合疗法在该患者人群中的安全性及耐受性。

The new data further demonstrate that BI 655066 has similar safety and tolerability to ustekinumab, regardless of dose, with no serious drug-related side-effects.
新数据进一步证明，BI655066与ustekinumab的安全性和耐受性相似（不考虑剂量），无严重药物相关副作用。

Other endpoints included progression-free survival and overall response rate determined by investigator, and the safety and tolerability of this combination in this patient population.
其他终点包括由研究人员确定的无恶化生存和总缓解率以及联合疗法在该患者人群中的安全性及耐受性。

A recent analysis of five clinical trials to assess the safety and tolerability of Tafenoquine has been published in Travel Medicine and Infectious Disease.
最近评估Tafenoquine安全性和耐受性的五项临床试验结果分析发表在《TravelMedicineandInfectiousDisease》上。

Unfortunately, Allergan decided to withdraw their Phase 1 trial evaluating the safety and tolerability of the drug prior to patient recruitment in November 2018.
不幸的是，艾尔建决定在2018年11月招募患者之前撤销对该药物安全性和耐受性评估的Ⅰ期试验。

Forty Seven's Phase 1 trial was designed to evaluate the safety and tolerability of 5F9 and to define a recommended dose and schedule.
FortySeven的另外一项1期试验旨在评估5F9的安全性和耐受性，并确定推荐的剂量和时间表。

Safety results were consistent across the trials and further reinforce the long-term safety and tolerability profile of filgotinib for a broad range of RA patients.
安全性结果在整个FINCH项目中是一致的，进一步加强了filgotinib在广泛的RA患者群体中的长期安全性和耐受性。